Treatment of lupus nephritis.
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000328:Adult; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D001379:Azathioprine / Q000008:administration & dosage; D002699:Chlorambucil / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D008466:Mechlorethamine / Q000008:administration & dosage; D008775:Methylprednisolone / Q000008:administration & dosage; D051379:Mice; D008814:Mice, Inbred NZB; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage
D000305:Adrenal Cortex Hormones; D002699:Chlorambucil; D008466:Mechlorethamine; D003520:Cyclophosphamide; D001379:Azathioprine; D011241:Prednisone; D008775:Methylprednisolone